Intellectus Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
14,422
-259
-2% -$22.7K 0.23% 116
2026
Q1
$1.25M Buy
14,681
+795
+6% +$70.9K 0.26% 107
2025
Q4
$1.1M Buy
13,886
+6,158
+80% +$483K 0.21% 121
2025
Q3
$618K Buy
+7,728
New +$659K 0.12% 182
2025
Q1
Sell
-8,282
Closed -$753K 275
2024
Q4
$753K Buy
+8,282
New +$790K 0.17% 157
2024
Q3
Sell
-6,657
Closed -$646K 276
2024
Q2
$646K Buy
+6,657
New +$614K 0.18% 154
2022
Q1
Sell
-6,765
Closed -$577K 239
2021
Q4
$577K Buy
6,765
+441
+7% +$34.4K 0.15% 165
2021
Q3
$478K Sell
6,324
-1,704
-21% -$135K 0.12% 192
2021
Q2
$653K Buy
8,028
+70
+0.9% +$5.72K 0.15% 170
2021
Q1
$627K Buy
+7,958
New +$624K 0.17% 166
2018
Q4
Sell
-4,981
Closed -$333K 295
2018
Q3
$333K Buy
4,981
+78
+2% +$5.2K 0.12% 185
2018
Q2
$318K Buy
+4,903
New +$321K 0.12% 185
2018
Q1
Sell
-7
Closed -$1K 597
2017
Q4
$1K Hold
7
﹤0.01% 592
2017
Q3
$1K Hold
7
﹤0.01% 750
2017
Q2
$1K Buy
+7
New +$520 ﹤0.01% 737

Other funds holding CL

Intellectus Partners's CL Position: Q2 2026 in Review

Intellectus Partners reduced its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, selling an estimated $22.7K and leaving 14,422 shares worth $1.32M. The position accounts for 0.23% of the portfolio, ranked #116.

Intellectus Partners first reported a position in CL in Q2 2017 and has held it in 15 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Intellectus Partners held 14,422 shares of Colgate-Palmolive worth $1.32M as of Q2 2026.
  • Intellectus Partners sold 259 Colgate-Palmolive shares in Q2 2026, an estimated $22.7K.
  • Colgate-Palmolive made up 0.23% of Intellectus Partners's portfolio in Q2 2026, its #116 holding.
  • Intellectus Partners first reported a position in Colgate-Palmolive in Q2 2017 and has held it in 15 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.